Albireo Pharma Inc. (ALBO) Fundamentals

Albireo Pharma Inc is a commercial-stage biopharmaceutical company. It focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders. The Company's product pipeline includes Bylvay, which is approved in the United States and Europe; elobixibat, which is approved in Japan for the treatment of chronic constipation; A3907, its Phase 1 lead candidate for the treatment of adult liver diseases; and A2342, it's a lead preclinical candidate for the treatment of adult viral and liver diseases.
SHARE INFORMATION
Market CapUS$ 413.647.620
Shares Outstanding19.576.319
Float14.721.176
Percent Float75,2%
Short Interest0,00
Short Percent Float0,0%
Short Interest Ratio0,00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0,00
Latest Fiscal RevenueUS$ 40.579.000
Latest Fiscal EPSUS$ -1,86
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)US$ 0,00
Dividend (5 Years)US$ 0,00
Ex Dividend Date-
Dividend RateUS$ 0,00
Dividend Yield0,0%
Payment Cash-
HOLDERS
Institutions296
Institutional Holdings Date2022-06-30
Institutional Bought Previous 3 Months1.417.772
Institutional Holdings Percent158,1%
Institutional Sold Previous 3 Months3.594.205
Insider Holdings Date2022-05-31
Insider Bought Previous 3 Months-
Insider Holdings Percent20,8
Insider Sold Previous 3 Months454
Insider Shares Owned4.076.141
TRADING INFO
52 Week HighUS$ 37,86
52 Week LowUS$ 17,81
52 Week High ChangeUS$ -41,09
21 Day Moving AverageUS$ 19,8495
21 Day Extended Moving AverageUS$ 20,3416
50 Day Moving AverageUS$ 24,0767
50 Day Extended Moving AverageUS$ 23,1226
200 Day Moving AverageUS$ 27,5815
200 Day Extended Moving AverageUS$ 27,442
10 Day Average Volume298.134
20 Day Average Volume280.373
30 Day Average Volume288.408
50 Day Average Volume313.691
Alpha0.001863
Beta0.9257
Standard Deviation0.145768
R20.096372
7 Day Price ChangeUS$ 1,66
7 Day Percent Change8,53%
21 Day Price ChangeUS$ 0,94
21 Day Percent Change4,66%
30 Day Price ChangeUS$ 1,49
30 Day Percent Change7,59%
Month to Date Price ChangeUS$ 1,27
Month to Date Percent Change6,39%
Quarter to Date Price ChangeUS$ 1,27
Quarter to Date Percent Change6,39%
180 Day Price ChangeUS$ -2,16
180 Day Percent Change-9,27%
200 Day Price ChangeUS$ -0,47
200 Day Percent Change-2,18%
Year to Date Price ChangeUS$ -2,16
Year to Date Percent Change-9,27%

Albireo Pharma Inc. (ALBO) Key Ratios

PROFITABILITY
EBIT Margin-43,7%
EBITDA Margin-43,0%
Pre-Tax Profit Margin-484.510,7%
Profit Margin Count-1,68%
Gross Margin96,5%
Profit Margin TOT-1,68%
INCOME STATEMENTS
RevenueUS$ 43.017.000
Revenue Per ShareUS$ 2,1974
Revenue (3 Years)US$ 0,00
Revenue (5 Years)US$ 0,00
FINANCIAL STRENGTH
Price to Tangible Book3,20
Total Debt To Equity0,10
Int Coverage-1,50
Current Ratio7,30
Leverage Ratio1,70
Quick Ratio6,90
Long Term Debt To Capital0,06
VALUATION MEASURES
PE Ratio-12,00
Enterprise ValueUS$ 207.072.620
Price to Sales9,6159
Price to Free Cash-5,40
PE High Last 5 Years-1,60
Price To Book2,80
Price To Cash Flow0,00
PE Low Last 5 Years-6,00
Price to Tangible Book3,20
MANAGEMENT EFFECTIVENESS
Receivables Turnover66,30
Invoice Turnover1,70
Assets Turnover0,20
Return Assets-13,17
Return on Equity-22,74
Return on Capital-12,61

Albireo Pharma Inc. (ALBO) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEORonald H.W. Cooper
Emplyoees130
Last AuditUQ
CIK0001322505
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address53 State Street
19th Floor
Boston, MA 2109
Websitehttps://www.albireopharma.com
Facsimile-
Telephone+1 857 254-5555
Emailmedinfo@albireopharma.com
Kürzlich von Ihnen besucht
NASDAQ
ALBO
Albireo Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Der Markt LS (Lang&Schwarz) wird als Realtime Indikation kostenlos angezeigt und bietet Ihnen außerbörsliche Realtime Aktienkurse in der Zeit von Mo-Fr 08:00 bis 23:00, Samstags 10:00 bis 13:00 und Sonntags an.
NYSE und AMEX Kurse sind um mindestens 20 Minuten zeitverzögert.
Alle weiteren Kurse sind um mindestens 15 Minuten zeitverzögert, sofern nicht anders angegeben.

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

P: V:de D:20220705 09:08:43